...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024

YouTube:

I give it 8 out of 10. (pretty good) 

https://www.youtube.com/watch?v=pw1Rsm1UR3o

 

Koo

Share
New Message
Please login to post a reply